1-866-647-3279

28

Apr 2026

Monitoring Safety in Probiotic Clinical Studies: Key Considerations
Monitoring Safety in Probiotic Clinical Studies: Key Considerations
By
Probiotics are widely regarded as safe in healthy populations. However, as clinical research moves toward targeted, high-potency, and therapeutic outcomes, safety monitoring must evolve. Living organisms interact dynamically with the […] Read More >>

28

Apr 2026

Designing Placebo Controls for Probiotic Trials: Key Considerations
Designing Placebo Controls for Probiotic Trials: Key Considerations
By
Placebo-controlled studies remain the gold standard for demonstrating efficacy in clinical research. However, in probiotic trials, designing an appropriate placebo is far from straightforward. Unlike conventional pharmaceuticals, probiotics are living [&he Read More >>

31

Mar 2026

Maintaining Blinding Integrity in Probiotic and Live Biotherapeutic Trials
Maintaining Blinding Integrity in Probiotic and Live Biotherapeutic Trials
By
Blinding is a cornerstone of clinical trial design, but in probiotic and live biotherapeutic product (LBP) studies, it is uniquely fragile. Unlike conventional pharmaceuticals, probiotics and LBPs are living systems. […] Read More >>

11

Mar 2026

Designing a Probiotic Clinical Trial: Key Decisions Sponsors Must Get Right
Designing a Probiotic Clinical Trial: Key Decisions Sponsors Must Get Right
By
Probiotic trials rarely fail for a single reason. More often, problems emerge from a series of early design decisions that were never fully aligned: the strain chosen doesn’t match the […] Read More >>

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions